apollo
logo
0Login
Introducing Our Latest Arrival!
Lignowin 21.3mg Injection

Lignowin 21.3mg Injection

Prescription drug
 Trailing icon
Consult Doctor

Composition

LIDOCAINE-21.3MG

Manufacturer/Marketer

Ikon Remedies Pvt Ltd

Consume Type

PARENTERAL

Return Policy

Not Returnable

for this medicine

About Lignowin 21.3mg Injection

Lignowin 21.3mg Injection is indicated for the production of regional or local anaesthesia during surgery or medical procedures. Additionally, it is indicated in the management of ventricular arrhythmia (abnormal heartbeat) associated with acute myocardial infarction, or cardiac surgery. 

Lignowin 21.3mg Injection contains ‘Lidocaine’ that blocks the influx (entry) of sodium ions into the membrane that surrounds the nerves, thereby preventing initiation and conduction of impulses; hence providing an anaesthetic effect. Lignowin 21.3mg Injection blocks cardiac sodium channels, thereby treating arrhythmia.

Lignowin 21.3mg Injection will be administered by a healthcare professional; do not self-administer. In some cases, you may experience certain common side-effects such as dizziness, high/low blood pressure, nausea, vomiting, and paresthesia (burning or prickling sensation). You are advised to talk to your doctor if you experience these side effects persistently.

Do not take Lignowin 21.3mg Injection if you are allergic to any of its components. Consult your doctor if you are pregnant, planning for pregnancy or breastfeeding. Avoid driving or operating machinery as Lignowin 21.3mg Injection may cause dizziness, drowsiness, and loss of sensation. Keep your doctor informed about your health condition and medications to rule out any interactions/side effects.

Uses of Lignowin 21.3mg Injection

Used for Local anesthesia and treatment of ventricular arrhythmia

Medicinal Benefits

Lignowin 21.3mg Injection is indicated for the production of regional or local anaesthesia in case of surgeries or medical procedures. Also, it is indicated in the management of ventricular arrhythmias (abnormal heartbeat) associated with acute myocardial infarction, or cardiac surgery. Lignowin 21.3mg Injection blocks the influx (entry) of sodium ions into the membrane that surrounds the nerves, thereby preventing initiation and conduction of impulses and hence providing an anaesthetic effect. It blocks cardiac sodium channels, thereby treating arrhythmia.

Directions for Use

Lignowin 21.3mg Injection will be administered by a healthcare professional. Do not self-administer.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Lignowin 21.3mg Injection

  • Nausea
  • Vomiting
  • High/low blood pressure
  • Dizziness
  • Paresthesia (burning or prickling sensation)

Drug Warnings

Do not take Lignowin 21.3mg Injection if you are allergic to any of its components. Inform your doctor if you have hypovolemia (low blood volume), blood clotting problems, bleeding problems, slow heart rate, myasthenia gravis (muscle problems), epilepsy, heart, kidney or liver problems. Consult your doctor if you are pregnant or breastfeeding. Avoid driving or operating machinery as Lignowin 21.3mg Injection may cause dizziness, drowsiness and loss of sensation. Keep your doctor informed about your health condition and medications to rule out any interactions/side effects.

Drug Interactions

Drug-Drug Interactions: Inform your doctor if you are taking other anaesthetics, antiarrhythmics, anti-viral agents, sedatives, beta-blockers (metoprolol, propranolol), calcium channel blockers (amiodarone), vasoconstrictors (epinephrine, norepinephrine), antacid (cimetidine), anti-convulsants (phenobarbital, phenytoin, carbamazepine, primidone), antibiotic (erythromycin), anti-psychotics (fluvoxamine).

Drug-Food Interactions: No interactions found/established.

Drug-Disease Interaction: Inform your doctor if you have hypovolemia (low blood volume), blood clotting problems, bleeding problems, slow heart rate, myasthenia gravis (muscle problems), epilepsy, heart, kidney or liver problems.

Drug-Drug Interactions Checker List

  • METOPROLOL
  • PROPRANOLOL
  • AMIODARONE
  • EPINEPHRINE
  • NOREPINEPHRINE
  • CIMETIDINE
  • PHENOBARBITAL
  • PHENYTOIN
  • CARBAMAZEPINE
  • PRIMIDONE
  • ERYTHROMYCIN
  • FLUVOXAMINE

Habit Forming

No

Diet & Lifestyle Advise

  • Include a diet rich in whole grains, lean proteins, vegetables, and fruits.
  • Avoid smoking and alcohol consumption.
  • Maintain a healthy weight with a proper diet and safe exercises.
  • Manage stress with meditation and yoga.

Disease/Condition Glossary

Local anaesthesia: It causes numbing/loss of sensation to a specific area of the body. It is used to treat pain, or to prevent pain during surgery or medical procedure.

Ventricular arrhythmia: Ventricular arrhythmia is a condition in which abnormal heartbeats originate in the ventricles (lower chambers of the heart). This limits/prevents the heart's ability to pump blood throughout the body. Symptoms include palpitations (a feeling as if the heart is pounding), chest pain, fainting, sweating, shortness of breath, and light-headedness.

bannner image

Alcohol

Caution

It is not known if alcohol affects Lignowin 21.3mg Injection. Please consult your doctor if you have any concerns regarding this.

bannner image

Pregnancy

Caution

Please consult your doctor if you are pregnant or planning for pregnancy. Your doctor will prescribe only if the benefits outweigh the risks.

bannner image

Breast Feeding

Caution

Please consult your doctor if you are breastfeeding. Your doctor will decide if Lignowin 21.3mg Injection can be taken by breastfeeding mothers or not.

bannner image

Driving

Caution

Avoid driving or operating machinery as Lignowin 21.3mg Injection may cause dizziness, drowsiness and loss of sensation.

bannner image

Liver

Caution

Lignowin 21.3mg Injection should be used with caution in patients with liver impairment/liver disease. Please consult your doctor if you have any concerns regarding this.

bannner image

Kidney

Caution

Lignowin 21.3mg Injection should be used with caution in patients with kidney impairment/kidney disease. Please consult your doctor if you have any concerns regarding this.

bannner image

Children

Caution

Limited information is available. Please consult your doctor if you have any concerns regarding the usage of Lignowin 21.3mg Injection in children.

Country of origin

India
Other Info - LI91156

Author Details

Doctor imageWe provide you with authentic, trustworthy and relevant information

FAQs

Lignowin 21.3mg Injection is indicated for the production of regional or local anaesthesia during surgery or medical procedures. Additionally, it is indicated in the management of ventricular arrhythmia (abnormal heartbeat) associated with acute myocardial infarction, or cardiac surgery.
Lignowin 21.3mg Injection blocks the influx (entry) of sodium ions into the membrane that surrounds the nerves, thereby preventing initiation and conduction of impulses and hence providing an anaesthetic effect. Lignowin 21.3mg Injection blocks cardiac sodium channels, thereby treats arrhythmia.
Lignowin 21.3mg Injection may cause hypotension (low blood pressure) or hypertension (high blood pressure). Therefore, regular monitoring of blood pressure is advised whilst on treatment with Lignowin 21.3mg Injection.
Nausea and vomiting might be a side effect of Lignowin 21.3mg Injection. It is not necessary for everyone taking Lignowin 21.3mg Injection to experience these side effects. However, if the condition persists or worsens, please consult a doctor.
Lignowin 21.3mg Injection might increase creatinine phosphokinase levels. Therefore, if you are undergoing any tests, inform the person doing the tests that you have taken Lignowin 21.3mg Injection.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.